These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 16049287)
1. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. Saitou M; Goto M; Horinouchi M; Tamada S; Nagata K; Hamada T; Osako M; Takao S; Batra SK; Aikou T; Imai K; Yonezawa S J Clin Pathol; 2005 Aug; 58(8):845-52. PubMed ID: 16049287 [TBL] [Abstract][Full Text] [Related]
2. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Tamada S; Shibahara H; Higashi M; Goto M; Batra SK; Imai K; Yonezawa S Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4257-64. PubMed ID: 16857800 [TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas. Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771 [TBL] [Abstract][Full Text] [Related]
5. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma. Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402 [TBL] [Abstract][Full Text] [Related]
7. Expression of MUC5AC and MUC6 in invasive ductal carcinoma of the pancreas and relationship with prognosis. Jinfeng M; Kimura W; Hirai I; Sakurai F; Moriya T; Mizutani M Int J Gastrointest Cancer; 2003; 34(1):9-18. PubMed ID: 15235131 [TBL] [Abstract][Full Text] [Related]
9. The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma. Zhu Y; Zhang JJ; Zhu R; Zhu Y; Liang WB; Gao WT; Yu JB; Xu ZK; Miao Y Med Oncol; 2011 Dec; 28 Suppl 1():S175-84. PubMed ID: 20922503 [TBL] [Abstract][Full Text] [Related]
10. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients. Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692 [TBL] [Abstract][Full Text] [Related]
12. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. Nakamura A; Horinouchi M; Goto M; Nagata K; Sakoda K; Takao S; Imai K; Kim YS; Sato E; Yonezawa S J Pathol; 2002 Jun; 197(2):201-10. PubMed ID: 12015744 [TBL] [Abstract][Full Text] [Related]
13. Significance of mucin expression in pancreatobiliary neoplasms. Yonezawa S; Higashi M; Yamada N; Yokoyama S; Goto M J Hepatobiliary Pancreat Sci; 2010 Mar; 17(2):108-24. PubMed ID: 19787286 [TBL] [Abstract][Full Text] [Related]
14. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. Yonezawa S; Nakamura A; Horinouchi M; Sato E J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144 [TBL] [Abstract][Full Text] [Related]
15. Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases. Ansari D; Urey C; Gundewar C; Bauden MP; Andersson R Scand J Gastroenterol; 2013 Oct; 48(10):1183-7. PubMed ID: 24047396 [TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia. Park HU; Kim JW; Kim GE; Bae HI; Crawley SC; Yang SC; Gum JR; Batra SK; Rousseau K; Swallow DM; Sleisenger MH; Kim YS Pancreas; 2003 Apr; 26(3):e48-54. PubMed ID: 12657964 [TBL] [Abstract][Full Text] [Related]
17. Analysis of c-kit protein expression in pancreatic neoplasms and its implication for prognosis. Kimura W; Ma J; Takeshita A; Yamamoto T; Moriya T; Hirai I; Fuse A Hepatogastroenterology; 2007 Dec; 54(80):2203-8. PubMed ID: 18265633 [TBL] [Abstract][Full Text] [Related]
18. Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism. Zhang JJ; Zhu Y; Xie KL; Peng YP; Tao JQ; Tang J; Li Z; Xu ZK; Dai CC; Qian ZY; Jiang KR; Wu JL; Gao WT; Du Q; Miao Y Mol Cancer; 2014 May; 13():130. PubMed ID: 24884523 [TBL] [Abstract][Full Text] [Related]
19. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas. Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504 [TBL] [Abstract][Full Text] [Related]
20. MUC4: a novel prognostic factor of oral squamous cell carcinoma. Hamada T; Wakamatsu T; Miyahara M; Nagata S; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K Int J Cancer; 2012 Apr; 130(8):1768-76. PubMed ID: 21618516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]